Prescription drug · BLA
Sucraid (Sacrosidase) NDC 67871-111
Sacrosidase 8500 [iU]/mL · Solution · Oral · QOL Medical, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 67871-111-04 | 67871011104 | 2 BOTTLE in 1 CARTON (67871-111-04) / 118 mL in 1 BOTTLE (67871-111-01)Marketed from Apr 9, 1998 | |
| 67871-111-07 | 67871011107 | 6 BOX in 1 CARTON (67871-111-07) / 25 POUCH in 1 BOX (67871-111-06) / 5 VIAL, SINGLE-USE in 1 POUCH (67871-111-05) / 2 mL in 1 VIAL, SINGLE-USEMarketed from May 25, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sucraid
- Generic name (nonproprietary)
- sacrosidase
- Active ingredients
- Sacrosidase — 8500 [iU]/mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- QOL Medical, LLCNDC labeler code 67871
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 020772
- Marketing start
- Listing expires
- Identifiers
- Product ID 67871-111_4719ec33-5660-444a-e063-6294a90ab40cSPL ID 4719ec33-5660-444a-e063-6294a90ab40cSPL set ID d613bb7f-c3f4-462e-81a2-da2347cc4b6bRxCUI 213337, 312872UNII 8A7F670F2Y
- Pharmacologic class
- Sucrose-specific Enzyme
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N467871011104followed by a unit qualifier and the quantityPackage 67871-0111-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Sucraid ® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.
Excerpt only. Read the full label for complete information.
About NDC 67871-111
- What is NDC 67871-111?
- 67871-111 is the product NDC for Sucraid (sacrosidase), Sacrosidase 8500 [iU]/mL solution, listed with the FDA by QOL Medical, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Sucraid (Sacrosidase).
- What is the active ingredient?
- Sacrosidase.
- Who is the labeler?
- QOL Medical, LLC, NDC labeler code 67871. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Sucraid?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.